Merck Commits $2.9 Billion to Pennsylvania Vaccine and Drug Sites
Merck plans a $2.9 billion Pennsylvania expansion through 2030, including $550 million for West Point and Spring House research facilities.
1 min read
Merck plans a $2.9 billion Pennsylvania expansion through 2030, including $550 million for West Point and Spring House research facilities.
This story was originally published by Supply Chain 24/7. Read the full story at Supply Chain 24/7 →
Conversation